Professor of Childhood Cancer Research and Director of the Newcastle University Centre for Cancer @NU_Cancer. Views are my own.
Newcastle Upon Tyne, England
Joined December 2019
- Tweets358
- Following396
- Followers504
- Likes706
Pinned Tweet
You can also find me - and a rapidly growing number of interesting cancer folk - on Bluesky Social
@ProfSClifford.bsky.social
Merry Christmas Everyone!
This year, instead of Christmas cards, I’ve donated to the wonderful ‘Children with Cancer in Malawi’ charity justgiving.com/charity/child…. You could do the same if you’re interested?!
Wishing you all a happy and healthy 2026!
Steve Clifford retweeted
We're delighted to share that @UniofNewcastle has officially approved renewal of the #NUCancerCentre for 2025-30.
We look forward to continuing this important journey together over the next five years.
I’m pleased to be speaking at the @CRUKresearch’s upcoming children’s & young people’s cancers webinar on exploring further discoveries from clinical research. Join me on 12 February from 3–4:30 pm (GMT): bit.ly/3BsXMF0#ExploringCYPC… @NU_Cancer
Steve Clifford retweeted
🚨 Less than one week left until our #ExploringCYPCancers webinar. Join researchers at the interface between clinical & discovery research discussing how to learn more from #ClinicalTrials to improve outcomes for children’s & young people’s cancers 👉 bit.ly/3BsXMF0
Steve Clifford retweeted
📣Announcing more speakers at our upcoming #ExploringCYPCancers webinar on clinical research:
💡Steve Clifford (@NU_Cancer)
💡John Rainsbury (Little Hero)
Join us on 12 Feb, 3–4:30 pm to explore how to maximise learning from #ClinicalTrials: bit.ly/3BsXMF0
@ProfSClifford | @UniofNewcastle | @JohnRainsbury
ALT Steve Clifford (left), John Rainsbury (right)
Steve Clifford retweeted
PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nu_cancer
See findaphd.com/phds/project/ph…
PhD post available: Are you interested in using contemporary ‘omics approaches to uncover clinically-relevant biology in medulloblastoma, the most common malignant brain tumour in children? Join our Childhood Brain Tumour Research team @nu_cancer
See findaphd.com/phds/project/ph…
Steve Clifford retweeted
Looking for a PhD? Our multi-disciplinary team @NU_Cancer are using next-generation 'omics, AI, bioinformatics and biostatistics across pan-European clinical trials to improve outcomes for children with #medulloblastoma. See findaphd.com/phds/project/mr… or DM if you're interested.
Looking for a PhD? Our multi-disciplinary team @NU_Cancer are using next-generation 'omics, AI, bioinformatics and biostatistics across pan-European clinical trials to improve outcomes for children with #medulloblastoma. See findaphd.com/phds/project/mr… or DM if you're interested.
Steve Clifford retweeted
Exciting PhD opportunity seeking to reduce the therapy-associated late-effects burden in childhood cancer survivors, in our internationally-leading childhood cancer centre!
@NU_Cancer
@ChildCancerNTH
@halsey_lab
@DelFred010530 eur03.safelinks.protection.o…
Steve Clifford retweeted
We're proud to announce over 700 scholarships for international and EU students, welcoming applications from students of diverse backgrounds from across the world to support them in pursuing their degrees! 🎺🌎
Read more here. ⬇
#WeAreNCL
ncl.ac.uk/press/articles/lat…
Steve Clifford retweeted
Vital research led by our own Professor Steve Clifford could lead to treatments that improve survival rates of children diagnosed with Medulloblastoma, which is responsible for around 5% to 10% of childhood cancer deaths. 🔬
Read more here. ⬇
#WeAreNCL
ncl.ac.uk/press/articles/lat…
Studies find more targeted approach to treating childhood brain cancer ncl.ac.uk/press/articles/lat… @NU_Cancer @UniofNewcastle @NCL_medscience @SIOPEurope @CCLG_UK @ITCC_eu
Steve Clifford retweeted
Out now.....MYC-dependent upregulation of the serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma academic.oup.com/neuro-oncol… Great job Maggie and our amazing collabs @NU_Cancer @CwC_UK @BrainTumourOrg @GOSHCharity @ChildCancerNTH
Just published 2: Heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcome - picking out the bad actors from >1600 patients academic.oup.com/neuro-oncol… Well done @edschwalbe et al @NU_Cancer @CRUKresearch @CwC_UK @BrainTumourOrg @GOSHCharity
Revealing the 'worst of the worst' #medulloblastoma - new treatments urgently needed: Heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcome academic.oup.com/neuro-oncol… @edschwalbe @NU_Cancer @CRUKresearch @CwC_UK @BrainTumourOrg @GOSHCharity
Out now.....MYC-dependent upregulation of the serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma academic.oup.com/neuro-oncol… Great job Maggie and our amazing collabs @NU_Cancer @CwC_UK @BrainTumourOrg @GOSHCharity @ChildCancerNTH
